AbbVie Jumps 1.67% on Strategic Apogee Therapeutics Acquisition, Bolstering Immunology

🟢 AbbVie Jumps 1.67% on Strategic Apogee Therapeutics Acquisition, Bolstering Immunology | MarketDownload | MarketDownload